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During the last few years, we have achieved a good deal of
knowledge on the epidemiology of the rheumatic diseases in
the world. Along with recent studies on the prevalence of rheu-
matic diseases such as osteoarthritis (OA), regional pain syn-
dromes (RRPS), rheumatoid arthritis (RA), spondyloarthritides
(SpA) mainly ankylosing spondylitis (AS) and psoriatic arthri-
tis (PsA), fibromyalgia, gout, and some of the connective tissue
diseases, we have learned about risk factors for the occurrence
of these disorders in the community.
The prevalence of rheumatic diseases and related musculo-
skeletal disorders worldwide is very high, but when we look at
the prevalence of each disorder, we find variations in their rank
order [1, 2]. For example, OA and RPPS rank at the top in most
studies, but their prevalence might vary from 2.3 % in México
[3] to 20.4 % in Cuba [4]. Regarding RA, its prevalence goes
from 0.17 % in the Philippines [5] to 1.49 % in México [3].
These phenomena may be explained in different ways.
Perhaps, the most important relates to the study itself: sam-
pling, case index definition, diagnostic and classification
criteria, study design, and methodology. The use of homoge-
neous designs and definitions for epidemiological studies
might solve such differences. In this sense, we have followed
other studies in using the Community Oriented Program for
the Control of Rheumatic Diseases (COPCORD) program for
the detection of individuals with musculoskeletal (MSK) dis-
eases. Then, we have followed universal classification criteria
for each disease. In this way, we have minimized the role of
study design in disease prevalence variations.
As a group, rheumatic and other MSK diseases cause a
huge socioeconomic burden to patients and their household,
society, and the country indeed. Yet, their relevance is often
minimized, particularly in developing nations, countries with
fragmented health care system, and poor nations [6]. Latin
America, a geographic area that includes 26 countries, is
plagued by these and more local problems that make the care
of rheumatic patients certainly difficult.
The approach of the studies presented here and in previous
papers has been dimensioning the magnitude of the problem
by investigating the prevalence of various rheumatic diseases,
their cost, effect on functioning, impact in quality of life as
well as their clinical features. Our previous publications, in
particular, a multilevel analysis of OA [7] and RA [8] have
shown that speaking an indigenous language is associated
with the prevalence of RA. It is therefore that this approach
mainly focuses on some Latin American native populations.
It is undisputed that statistics and solid data that provide
information about the incidence, prevalence, mortality, and
impact of these conditions on the indigenous peoples of
Latin America are needed. As a response to this regional chal-
lenge, a Latin American group called GLADERPO (Grupo
Latino Americano de estudio De Enfermedades Reumaticas
en Pueblos Originarios) was created. This group complies
with the objective of carrying out epidemiological, genetic,
and anthropological studies related to rheumatic diseases in
indigenous peoples of Latin America. This project is placed
within the framework of this regional effort.
Now, we present in this volume of Epidemiology of rheu-
matic diseases in indigenous populations in Latin-Americans
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the results of a large study on the prevalence of rheumatic
disease in various indigenous populations in Latin America.
Noteworthy, we kept respect with the word and the concept
behind of Bindigenous^ people to name the population which
first originated in a particular land. The identification of these
people has been a constant and serious problem worldwide.
For example, the indigenous population of Australia is called
BAboriginal,^ in Canada Baboriginal people,^ in the USA
BAmerican Indians^ and BAlaskan Natives.^ In Argentina,
Venezuela, and Mexico, the denomination is Bindigenous^
or Boriginal^ [9–11].
Nonetheless, the debate is far beyond people’s name; it also
includes the denominations given to indigenous, governmen-
tal, non-governmental, and academic institutions as well as the
use of language and self-recognition as variables that define
indigenous people [10]. The identification of indigenous peo-
ple is problematic; certain information, for example, that re-
lated on the effect of health care among indigenous groups in
Mexico and other Latin American countries is scarce [11]. In
this study, we have therefore relied on auto-identification
criteria as well as framework of law pertaining to each partic-
ipating country.
The populations included in this study was the Maya-
Yucateco, Mixtec, Chontal, and Rarámuri from Mexico;
Warao, Kari’ña, and Chaima from Venezuela; and Qom from
Argentina. The design of the study, including sampling, case
definition, and methodology, were similar to all studies.
Basically, sampling was a Bcensus,^ case definition was
Bindividuals with musculoskeletal pain, stiffness or swelling
in the last 7 days and/or at any point during their lifetime,^ and
methodology was that proposed by COPCORD.
In this sense, the information presented here is unique since
it includes a total of 6155 indigenous people from eight com-
munities in three countries assessed by the same questionnaire
and evaluated by current classification criteria and expert’s
opinion.
Overall, low back pain (13.3 %; 95%CI 12.4–14.2), OA
(9.7 %; 95%CI 8.9–10.4), and RPPS (5.9 %; 95%CI 5.3–6.6)
were the most prevalent rheumatic disease across all popula-
tions. Regarding some examples showing wide variations in
the prevalence of certain diseases among the different popu-
lations, the prevalence of RAwas 2.4 % in Qom and 0.4 % in
Mixtec, low back pain 19.8 % in Qom and 1.5 % in Rarámuri,
and OA in 32.1 % in Chontal and 3.8 % in Qom. In Mixtec,
the prevalence of MSK pain in the last 7 days or at any point
during their lifetime occurred in 46.1 and 65.3 % but 20 and
14.4 % in Raramuris. Variations were not related to the design
of the study but to the characteristics of the population and
environmental factors, for example heavy loads in Chontales
versus Rarámuris or Maya-Yucateco in people not exposed to
the same environment.
Parallel anthropological studies have identified barriers
preventing the access of indigenous population, particularly
those with RA to medical care. The fact that the Mayan-
Yucateco, Qom, and Warao are mostly monolingual hinders
the communication with health providers. There are also geo-
graphical barriers that preclude many patients to benefit from
health care in specialized centers and on the other hand the
lack of institutional health universal coverage such as the
Mexican populations [12].
The information gathered here may open a new set of pos-
sibilities to develop new and more advanced epidemiological
and anthropological studies and particularly the design of in-
terventional studies in the community for an early detection of
the rheumatic diseases and generation of strategies to prevent
their short and long-term consequences to implement public
policies on musculoskeletal health and disability.
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